Saturday, 03 December 2022

 

 

LATEST NEWS Washington Sundar is a treasure India have unearthed : Laxman Sivaramakrishnan Elon Musk reveals how Twitter suppressed Hunter Biden laptop story in 2020 Vicky Kaushal gets a picture clicked with Sam Manekshaw's statue Russian woman raped in Goa, 2 Nepali nationals held Ricky Ponting returns to the commentary box at Perth; details his health scare India's G20 Presidency will boost global economy, open Internet : Sundar Pichai 'Bigg Boss 16' host Salman Khan schools Archana Gautam Umran Malik replaces injured Mohammed Shami in India's ODI squad for series against Bangladesh Google shuts AI-driven service 'Duplex on the Web' US President Joe Biden's approval rating hits record high Cameroon stun Brazil 1-0 but fail to qualify for knockout as Switzerland qualify PKL 9 : Jaideep, Meetu star as Haryana Steelers beat Bengal Warriors FIFA World Cup : Uruguay's 2-0 victory over Ghana goes in vain as two-time former champions crash out FIFA World Cup : Asian delight as South Korea stun Portugal to qualify for knockouts 'Power of people was undone, world doesn't know of any such instance': Jagdeep Dhankhar PKL 9 : Gujarat Giants beat Patna Pirates 40-34, dent their playoffs hopes Joe Biden will support 'dear friend' Narendra Modi during India's G-20 Presidency Navy being equipped with latest ships to protect maritime borders : Rajnath Singh India missed a leg-spinner in T20 WC, pressure to perform at big stage affect 'Men in Blue' at ICC events : Moeen Ali PKL 9 : Pardeep Narwal helps U.P Yoddhas ease past U Mumba 38-28 Nathan Lyon surpasses Dale Steyn to become 9th highest wicket-taker in Test cricket

 

Serum Institute of India to apply for Oxford vaccine trials in India in a week

Web Admin

Web Admin

5 Dariya News

New Delhi , 20 Jul 2020

The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine.Commenting on the AstraZeneca-Oxford  vaccine's results, Adar Poonawalla, CEO, Serum Institute of India, said, "The trials have shown promising results and we are extremely happy about it. We will be applying for the  licensure trials to the Indian regulator in a week's time. As soon as they grant us permission, we will begin with trials for the vaccine in India. In addition, we will soon start  manufacturing the vaccine in large volumes."Monday marked an important day in the battle against Covid as the first results of Oxford's Covid-19 vaccine showed that it is safe  and provokes an immune reaction in a person that lasts for almost two months.The researchers are indicating that the vaccine may be ready by year end. The results showed  that more than 91 per cent of volunteers injected produced an immune response against coronavirus which lasted for a month or more. The immune responses remained strong  for at least 56 days.Oxford University's vaccine, called AZD1222, is being manufactured by pharmaceutical major AstraZeneca and the UK government has ordered 100 million  doses ahead of time.As per the results, the vaccine boosted T cell and antibody immunity. The vaccine produced strong responses on both accounts, the study found, with T cell  immunity peaking after two weeks and then dropping slightly by day 56.Antibody immunity, on the other hand, peaked after four weeks and remained high by day 56, indicating  that it may well last for even longer.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Serum Institute of India , SII

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD